© 2022 Vial. All rights reserved
Bladder Cancer Director at the Dana-Farber Cancer Institute and Associate Professor of Medicine at Harvard Medical School
Dr. Sonpavde is a leading urological oncologist with a specialty in bladder cancer. He has led translational projects and developed prognostic classifications and endpoints focused on bladder cancer. In addition to his roles at the Dana-Farber Cancer Institute and Harvard Medical School, Dr. Sonpavde is a member of the Genitourinary Committee of Southwest Oncology Group (SWOG) and the Bladder Cancer Task Force of the National Cancer Institute Genitourinary Steering Committee. He completed his medical oncology fellowship at Indiana University.